Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer

M. K. C. Lee; J. M. Loree

doi:10.3747/co.26.6145

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Erratum

1 December 2019

Erratum: Current and Emerging Biomarkers in Metastatic Colorectal Cancer

and

BC Cancer, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada

Author to whom correspondence should be addressed.

Curr. Oncol.2019, 26(6), 404;https://doi.org/10.3747/co.26.6145

Version Notes

Order Reprints

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

In the initially published manuscript, the article stated (about the BEACON clinical trial) that “Interestingly, the triplet did not appear more active than the combination of encorafenib and binimetinib (mos: 9.0 months vs. 8.4 months; HR: 0.79; 95% CI: 0.59 to 1.06).” [...]

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Impact of the Gut Microbiome on Immune Checkpoint Inhibitor Efficacy—A Systematic Review

Countercurrents: The Bias of Choice